NCT00078286View on ClinicalTrials.gov

Antidepressant Medication Treatment for Depression in Individuals With Chronic Heart Failure

PHASE2/PHASE3CompletedINTERVENTIONAL

Enrollment

469

Participants

Timeline

Start Date

November 30, 2003

Primary Completion Date

March 31, 2008

Study Completion Date

September 30, 2008

Conditions

Heart Failure, CongestiveChronic Heart FailureDepression

Interventions

DRUG

Sertraline

Dosage ranging from 50 mg to 200 mg once a day

DRUG

Placebo

Dosage ranging from 50 mg to 200 mg once a day

Trial Locations (1)

27710

Duke Medical Center, Durham

Sponsors

Lead Sponsor

Duke University

All Listed Sponsors

collaborator

National Institute of Mental Health (NIMH)

NIH

lead

Duke University

OTHER